Please login to the form below
genomes
This page shows the latest genomes news and features for those working in and with pharma, biotech and healthcare.
MSD taps Austria’s Themis to bolster vaccine pipeline
measles virus genome to incorporate genes for antigens.
Latest news
-
Illumina sets up first ex-US accelerator site in Cambridge
Cambridge is of course also where Illumina was carrying out the DNA sequencing for the UK’s 100, 000 Genomes Project, in collaboration with Genomics England and other partners such as
-
Genentech taps into Sosei Heptares GPCR expertise with $1bn alliance
GPCRs are the largest family of proteins found in the membranes of cells, with upwards of 375 GPCRs known to be encoded in the human genome.
-
FDA will maintain the pace, vows Woodcock, but warns of skills gap
In fact, Dr. Woodcock believes that the drug industry is just beginning to see the fruits of the human genome sequencing and expects more and more approvals in future years,” the
-
Mistrust of pharma still blocking NHS collaborations
The 100, 000 Genomes Project, and the UK Biobank are two leading examples of this, which both sides want to see adopted and replicated in other projects.
-
England to fast-track tumour agnostic drugs like Vitrakvi – if the price is right
its world-leading 100, 000 Genomes Project.
More from news
Approximately 9 fully matching, plus 151 partially matching documents found.
Latest Intelligence
-
25 Women Leaders in UK Healthcare
She is also senior responsible officer (SRO) for the NHS Genomics Programme and has played a crucial role in enabling the groundbreaking 100, 000 Genomes Project by ensuring these healthcare scientists ... centre run by Illumina, and an automated
-
25 Women Leaders in UK Healthcare (part 2)
23. DR LARISSA KERECUK. Rare disease leader. England’s groundbreaking 100, 000 Genomes Project hasn’t been a scientific endeavour achieved exclusively through lab technology – it has required thousands of rare ... Dr Kerecuk is the lead for the
-
Genomics integration: can the NHS rise to the challenge?
This time, it hopes to sequence five million genomes within the next five years. ... When the first human genome was sequenced it took 13 years and £2bn to come to completion.
-
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
Genomics. Genomics England and its 100, 000 Genomes project has helped put the UK at the forefront of genomics.
-
2019: CRISPR and therapeutic gene editing comes of age
However, instead of restoring the original sequence, CRISPR serves as a new template that can be used to change the sequence, allowing the genome to be edited practically on demand. ... Before CRISPR, the introduction of zinc-finger nucleases (ZFNs) and
More from intelligence
Approximately 1 fully matching, plus 32 partially matching documents found.
Latest appointments
-
Editas Medicine names James Mullen as chairman
He has previously served as CEO of Patheon. Genome editing company Editas Medicine has appointed James Mullen as chairman of the board of directors.
-
Editas Medicine adds to its board of directors
Jessica Hopfield will also serve on the genome editing firm's audit committee. ... Genome editing company Editas Medicine has strengthened its board of directors with the addition of Jessica Hopfield, who will also serve on the board's audit committee.
-
Former GSK CEO joins Synthego’s advisory board
I look forward to contributing to the company’s success as the business extends further into the genome engineering market.”. ... Andrew’s appointment strengthens the company’s position as a leader in genome engineering solutions.”.
-
Paul Stockdale joins Oxford BioDynamics as CFO
A spin-out from Oxford University, Oxford BioDynamics focuses on the discovery and development of epigenetic biomarkers based on regulatory genome architecture.
-
Intellia Therapeutics appoints Dr Moncef Slaoui and Dr Frank Verwiel
They will join the board of directors. Genome editing group Intellia Therapeutics has appointed Moncef Slaoui and Frank Verwiel to join its board of directors at a time when the board ... We look forward to their guidance as we continue to advance our
More from appointments
Approximately 0 fully matching, plus 14 partially matching documents found.
Latest from PMHub
-
A uniquely English genomic medicine service
This process can take years, but Genomics England believes whole genome sequencing could provide much faster results. ... Helping these patients will mean carrying out whole genome sequencing upfront, before other genetic tests are conducted.
-
Learning about Rare Genetic Disorders on Undiagnosed Children’s Day
The UK has become the first country to take Whole Genome Sequencing, a cutting-edge biotechnology, into mainstream healthcare. ... Rather than looking at the genetic makeup of just the 20, 000 genes known to cause disorders, the whole genome is analysed.
-
Secrets of Pharma Advertising
Programmatic advertising that bombards you with ads for garden gnomes because you did a search on the human genome.
-
World AIDS Day 2018: Fighting the stigma surrounding HIV
10. Tenofovir – a nucleotide reverse transcriptase inhibitor (NtRTI). 11. Acts as a nucleotide analogue that competitively inhibits reverse transcriptase, the enzyme required for replication of the viral genome.
-
Artificial Intelligence in Healthcare
However, the robots received ‘points’ for finding the resource themselves and only the highest-scoring robots were ‘mated’; their binary code ‘genome’ forming part of the next generation of robots.
More from PMHub
Approximately 3 fully matching, plus 15 partially matching documents found.
Featured jobs
- FREELANCE Account Director – Healthcare Advertising – London – 3...
-
Competitive Daily Rates
- Account Director, Healthcare Communications
-
Salary TBC
- Senior Account Executive – Account Manager – Healthcare Advertis...
-
£32000 - £43000 Bonus Benfits
-
Account Director – UK Office
-
Excellent salary and benefits
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
Subscribe to our email news alerts
- Finch Therapeutics bags $53m for microbiome therapies
- MSD taps Austria’s Themis to bolster vaccine pipeline
- Early ‘no’ for GW Pharma’s epilepsy drug, but NICE vows to collaborate
- GSK preps filings for BCMA-targeting multiple myeloma drug
- Behaviour change – is there something missing?
- NICE’s long-serving chief exec Sir Andrew Dillon to step down
PMHub
Kendle Healthcare
Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...
Latest intelligence
- Empowered patients: shaking the foundations of healthcare
- Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
- A uniquely English genomic medicine service
- The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
- Blended Intelligence
- Data is the most valued commodity of the modern world. For P&P it's all about the application....
Quick links
Infographics
